3,988 research outputs found

    Ideas in ecology

    Get PDF
    Journal ArticleThe word "ecology" means different things to different people. For example, during the last 25 years or so the word has been used to label attitudes, life-styles, consumer goods, political parties, and college courses. In the 1960s one university renamed its "Home Economics" course "Home Ecology." (But our own biology department reacted to the growing visibility of its conventional "Ecology" course by renaming it "Population Biology.") It is often said that Thoreau coined the word "ecology." He certainly ought to have done so, given the Rousseauesque yearnings that surround the word, and this may be why the myth lives on, even though it stems from a 1958 misreading of the word "geology" as "ecology" in one of his letters (James 1985). The German biologist Haeckel was actually the first to use the word "Oecologie," in 1866

    Why do people (not) share guilt with others?

    Get PDF
    Do people share their feelings of guilt with others and, if so, what are the reasons for doing this or not doing this? Even though the social sharing of negative emotional experiences, such as regret, has been extensively studied, not much is known about whether people share feelings of guilt and why. We report three studies exploring these questions. In Study 1, we re-analysed data about sharing guilt experiences posted on a social website called "Yahoo Answers", and found that people share intrapersonal as well as interpersonal guilt experiences with others online. Study 2 found that the main motivations of sharing guilt (compared with the sharing of regret) were "venting", "clarification and meaning", and "gaining advice". Study 3 found that people were more likely to share experiences of interpersonal guilt and more likely to keep experiences of intrapersonal guilt to themselves. Together, these studies contribute to a further understanding of the social sharing of the emotion guilt. </p

    Toxic and Essential Trace Element Content of Commonly Administered Pediatric Oral Medications

    Get PDF
    OBJECTIVES: The aim of this study was to test the hypothesis that commonly administered pediatric oral medications are a significant source of toxic elements. The concentrations of 16 elements were determined in 14 frequently used pediatric oral medications. METHODS: Samples were prepared for analysis by dilution or nitric acid microwave-assisted digestion and analyzed by inductively coupled plasma mass spectrometry. The intake of each element from administration for 1 week of the medication\u27s maximum recommended daily dose to 6-month-olds was calculated and compared to an exposure guideline for that element. Exposure guidelines used for adverse effects were minimal risk levels, oral reference dose, permissible or permitted daily exposure, provisional tolerable weekly intake, and tolerable upper intake concentrations. Exposure guidelines utilized for desired effect were adequate intake and recommended dietary allowance. RESULTS: Intake of the maximum recommended daily dose by 6-month-olds for 1 week would not deliver more than the exposure guideline of any of the elements, with the exceptions of chromium in several medications and zinc in the pediatric electrolyte solution, if it was consumed for 1 week. CONCLUSIONS: Consumed alone, these frequently administered pediatric oral medications would not deliver amounts of toxic elements that exceed established exposure guidelines for adverse effects, nor would most significantly contribute to adequate intake of essential elements

    A Robust and Scalable Continuous Flow Process for Glycerol Carbonate

    Get PDF
    We report a robust continuous flow procedure for the synthesis of glycerol carbonate (2‐GLC) from green reagents glycerol and dimethyl carbonate (DMC), mediated by an inexpensive polymer‐supported base catalyst using methanol as co‐solvent. High conversion and selectivity were obtained, while residence times were typically shorter than 10 minutes

    Greedy bastards:Testing the relationship between wanting more and unethical behavior

    Get PDF
    Greed is often seen as immoral. Although the assumption that greed elicits unethical behavior is widespread, there is surprisingly little empirical research testing this relationship. We present a series of three studies investigating the association between greed and unethical behavior, using different methodologies and samples from the USA, The Netherlands, and Belgium. Study 1 (3 samples, total N = 3413) reveals that more greedy individuals find a variety of transgressions more acceptable and justifiable as well as indicate that they have more often engaged in a variety of transgressions compared to less greedy individuals. Study 2 (N = 172) replicated these findings in an incentivized behavioral laboratory study where participants decided to accept a bribe or not. Greedy people were more likely to take a bribe and also preferred higher bribes. Study 3 (N = 302) examined a potential process relating greed to unethical behavior. Greedy people were more likely to transgress because they found the positive outcomes associated with the transgression more desirable, and therefore displayed lower self-control. Implications for general theories of greed and morality are discussed

    The vulnerabilities of computerized physician order entry systems: a qualitative study

    Get PDF
    Objective To test the vulnerabilities of a wide range of computerized physician order entry (CPOE) systems to different types of medication errors, and develop a more comprehensive qualitative understanding of how their design could be improved. Materials and Methods The authors reviewed a random sample of 63 040 medication error reports from the US Pharmacopeia (USP) MEDMARX reporting system where CPOE systems were considered a β€œcontributing factor” to errors and flagged test scenarios that could be tested in current CPOE systems. Testers entered these orders in 13 commercial and homegrown CPOE systems across 16 different sites in the United States and Canada, using both usual practice and where-needed workarounds. Overarching themes relevant to interface design and usability/workflow issues were identified. Results CPOE systems often failed to detect and prevent important medication errors. Generation of electronic alert warnings varied widely between systems, and depended on a number of factors, including how the order information was entered. Alerts were often confusing, with unrelated warnings appearing on the same screen as those more relevant to the current erroneous entry. Dangerous drug-drug interaction warnings were displayed only after the order was placed rather than at the time of ordering. Testers illustrated various workarounds that allowed them to enter these erroneous orders. Discussion and Conclusion The authors found high variability in ordering approaches between different CPOE systems, with major deficiencies identified in some systems. It is important that developers reflect on these findings and build in safeguards to ensure safer prescribing for patients

    Clinical impact of MDR1-expression in testicular germ cell cancer

    No full text
    Aim: The multidrug resistance protein 1 (MDR1, P-gp, p-170) is a membrane glycoprotein that acts as an energy-dependent drug efflux pump. In various malignancies its expression is associated with resistance to diverse cytostatic drugs, and therefore predicts resistance to systemic treatment. The aim of this study was to investigate the prognostic value of MDR1 expression in primary tumor tissue to predict necrosis or viable cancer in residual tumor masses after systemic chemotherapy for advanced testicular germ cell cancer. Materials and Methods: Out of 77 patients, histopathological characteristics of primary testicular cancer specimens and retroperitoneal lymph node dissection (RPLND) samples following chemotherapy were available from 72 and all 77 patients, respectively. Moreover, MDR1 expression was determined by immunohistochemistry in 47 primary tumors and corresponding 73 RPLND sections. Results: After chemotherapy and subsequent RPLND, the examination of residual tumor masses revealed that mature teratoma and active viable tumor were predominantly found in patients with non-seminoma (NSGCT; p = 0.048), especially in those with containing mature teratoma (p = 0.001). Moreover, using univariate analysis the expression of MDR1 in the primary testicular tumor predicted viable tumor/teratoma residues in RPLND sections (p = 0.003). However, in multivariate analysis including the tumors’ histological subtype, MDR1 expression alone failed to reach statistical significance as an independent prognostic marker for residual vital tumor (p β‰₯ 0.16). Conclusions: With the limited number of patients given, the correlation between MDR1 expression in primary testis cancer and active residual retroperitoneal disease after chemotherapy failed to reach statistical significance as in independent marker. Therefore, up to now routine MDR1 staining of testicular germ cell cancer samples should not be performed in clinical practice. However, as there was a clear trend, a larger number of patients suffering from metastatic non-seminomas should be studied, as MDR1 expression might have significant prognostic value in this particular subgroup of patients.Π‘Π΅Π»ΠΎΠΊ 1 мноТСствСнной лСкарств Π΅Π½Π½ΠΎΠΉ устойчив ости (MDR1, P-gp, p-170) – это ΠΌΠ΅ΠΌΠ±Ρ€Π°Π½Π½Ρ‹ΠΉ Π³Π»ΠΈΠΊΠΎΠΏΡ€ΠΎΡ‚Π΅ΠΈΠ½, Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½ΠΈΡ€ΡƒΡŽΡ‰ΠΈΠΉ ΠΊΠ°ΠΊ энСргозависимый насос. ΠŸΡ€ΠΈ Ρ€Π°Π·Π» ΠΈΡ‡Π½Ρ‹Ρ… Ρ„ΠΎ Ρ€ΠΌΠ°Ρ… ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅ΠΉ Π΅Π³ΠΎ экспр Π΅ ссия связана с устойчив ΠΎ ΡΡ‚ΡŒΡŽ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ ΠΊ Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹ΠΌ цитостатикам, Ρ‡Ρ‚ΠΎ ΠΌΠΎΠΆΠ΅Ρ‚ Π±Ρ‹Ρ‚ΡŒ использовано для Π²Ρ‹Π±ΠΎΡ€Π° Ρ‚ΠΈΠΏΠ° Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ. ЦСль Ρ€Π°Π±ΠΎΡ‚Ρ‹ β€” исслСдованиС прогности- чСской значимости экспрСссии MDR1 Π² Ρ‚ΠΊΠ°Π½ΠΈ ΠΏΠ΅ Ρ€Π²ΠΈΡ‡Π½ΠΎΠΉ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ для ΠΎΡ†Π΅Π½ΠΊΠΈ Π²ΠΎΠ·ΠΌΠΎ Тности Ρ€Π°Π· вития Π½Π΅ΠΊΡ€ΠΎΠ·Π° ΠΈΠ»ΠΈ сохран Π΅ ния ΠΆΠΈΠ²Ρ‹Ρ… ΠΊΠ»Π΅Ρ‚ΠΎΠΊ Π² остаточной Ρ‚ΠΊΠ°Π½ΠΈ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ послС примСнСния систСмной Ρ…ΠΈΠΌΠΈΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Π½Π° ΠΏΠΎΠ·Π΄Π½ΠΈΡ… стадиях Π³Π΅Ρ€ΠΌΠΈΠ½Π°Ρ‚ΠΈΠ²Π½Ρ‹Ρ… ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅ΠΉ яичка. ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹: ΠΏΡ€ΠΎ Π°Π½Π°Π»ΠΈΠ·ΠΈΡ€ΠΎ Π²Π°Π½Ρ‹ гисто ΠΏΠ°Ρ‚ΠΎΠ»ΠΎ гичСскиС Ρ…Π°Ρ€Π°ΠΊΡ‚ Π΅ ристики ΠΏΠ΅ Ρ€Π²ΠΈΡ‡Π½ΠΎ ΠΉ Ρ‚Π΅ стикулярной ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ ΠΈ ΠΎΠ±Ρ€Π°Π·Ρ†ΠΎΠ², ΠΏΠΎΠ»ΡƒΡ‡Π΅Π½Π½Ρ‹Ρ… ΠΏΡ€ΠΈ иссСчСнии Ρ€Π΅Ρ‚Ρ€ΠΎΠΏΠ΅Ρ€ΠΈΡ‚ΠΎΠ½Π΅Π°Π»ΡŒΠ½Ρ‹Ρ… лимфатичСских ΡƒΠ·Π»ΠΎΠ² (RPLND) послС Ρ…ΠΈΠΌΠΈ ΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ 72 ΠΈ 77 Π±ΠΎΠ» ΡŒΠ½Ρ‹Ρ… соотвС тствСнно. Экспр Сссию MDR1 опрСдСляли ΠΈΠΌΠΌΡƒΠ½ огист ΠΎΡ…ΠΈΠΌΠΈΡ‡ Сским ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ Π² 47 ΠΎΠ±Ρ€Π°Π·Ρ†Π°Ρ… ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½ ΠΎΠΉ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ ΠΈ ΡΠΎΠΎΡ‚Π²Π΅Ρ‚ΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΡ… 73 ср RPLND. Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹: послС Ρ…ΠΈΠΌΠΈ ΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ ΠΈ ΠΏΠΎΡΠ»Π΅Π΄ΡƒΡŽΡ‰Π΅ΠΉ RPLNDисслСдовани Π΅ оста- Ρ‚ΠΎΡ‡Π½Ρ‹Ρ… ΠΎΠΏΡƒΡ…ΠΎΠ»Π΅Π²Ρ‹Ρ… Ρ‚ΠΊΠ°Π½Π΅ΠΉ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΎ, чтозрСлая Ρ‚Π΅Ρ€Π°Ρ‚ΠΎΠΌΠ° ΠΈ ТизнСспособныС ΠΎΠΏΡƒΡ… ΠΎΠ»Π΅Π²Ρ‹Π΅ ΠΊΠ»Π΅Ρ‚ΠΊΠΈ выяв Π»ΡΡŽΡ‚ прСимущСствСнно Ρƒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ…, Ρƒ ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… Π½Π΅ Π±Ρ‹Π»Π° ΠΎΠ±Π½Π°Ρ€ΡƒΠΆΠ΅Π½Π° сСминома (NSGCT; p = 0,048), особСнно Ρƒ Ρ‚Π°ΠΊ ΠΎΠ²Ρ‹Ρ… , Ρƒ ΠΊΠΎΡ‚ΠΎΡ€Ρ‹Ρ… Π±Ρ‹Π»Π° Ρ‚Π΅Ρ€Π°Ρ‚ΠΎΠΌΠ° (p = 0,001). Π‘ΠΎΠ»Π΅Π΅ Ρ‚ΠΎΠ³ΠΎ, Π΄ Π°Π½Π½Ρ‹Π΅ ΠΎΠ΄Π½ΠΎ Ρ„Π°ΠΊΡ‚ΠΎΡ€Π½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ, Ρ‡Ρ‚ΠΎ экспр Π΅ ссия MDR1 Π² Ρ‚ΠΊΠ°Π½ΠΈ ΠΏΠ΅ Ρ€Π²ΠΈΡ‡Π½ΠΎ ΠΉ Ρ‚Π΅ стику лярной ΠΎΠΏΡƒ- Ρ…ΠΎΠ»ΠΈ ΠΌΠΎΠΆΠ΅Ρ‚ ΡΠ»ΡƒΠΆΠΈΡ‚ΡŒ прогностич Сским Ρ„Π°ΠΊΡ‚ ΠΎΡ€ΠΎΠΌ сохран Сния ΠΆΠΈΠ²Ρ‹Ρ… ΠΎΠΏΡƒΡ… ΠΎΠ»Π΅Π²Ρ‹Ρ… ΠΊΠ»Π΅Ρ‚ΠΎΠΊ срСзах RPLND (p = 0,003). О Π½Π°ΠΊ ΠΎ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΌΡƒΠ»ΡŒΡ‚ΠΈΡ„Π°ΠΊΡ‚ΠΎΡ€Π½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π°, Π² Ρ‚ΠΎΠΌ числС с ΡƒΡ‡Π΅Ρ‚ΠΎΠΌ гистологичСского ΠΏΠΎΠ΄Ρ‚ΠΈΠΏΠ° ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ, ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΎ, Ρ‡Ρ‚ΠΎ экспр Π΅ ссия MDR1 Π½Π΅ ΠΈΠΌΠ΅Π΅Ρ‚ ΡΠ°ΠΌΠΎΡΡ‚ΠΎΡΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ прогностичСской значимости для выявлСния ΠΆΠΈΠ²Ρ‹Ρ… остаточных ΠΎΠΏΡƒΡ… ΠΎΠ»Π΅Π²Ρ‹Ρ… ΠΊΠ»Π΅Ρ‚ΠΎΠΊ (p 0,16). Π’Ρ‹Π²ΠΎΠ΄Ρ‹: Π²Π²ΠΈΠ΄Ρƒ нСбольшо ΠΉΠ²Ρ‹Π±ΠΎΡ€ΠΊΠΈΠ±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… Π½Π΅ выяв Π»Π΅Π½ΠΎ статистичСски значимойкоррСляции ΠΌΠ΅ΠΆΠ΄Ρƒ экспр СссиСй MDR1 Π² ΠΏΠ΅Ρ€Π²ΠΈΡ‡Π½ΠΎΠΉ ΠΎΠΏΡƒΡ…ΠΎΠ»ΠΈ яичка ΠΈ Π½Π°Π»ΠΈΡ‡ΠΈΠ΅ΠΌ Π°ΠΊΡ‚ΠΈΠ²Π½Ρ‹Ρ… Ρ€Π΅Π·ΠΈΠ΄ΡƒΠ°Π»ΡŒΠ½Ρ‹Ρ… ΠΎΡ‡Π°Π³ΠΎΠ² пораТСния Π² Ρ€Π΅Ρ‚Ρ€ΠΎΠΏΠ΅Ρ€ΠΈΡ‚ΠΎΠ½Π΅Π°Π»ΡŒΠ½ΠΎΠΌ пространствС. Π’ Ρ‚ ΠΎ ΠΆΠ΅ врСмя, учитывая Π²Ρ‹ΡΠ²Π»Π΅Π½Π½ΡƒΡŽ Ρ‚Π΅Π½Π΄Π΅Π½Ρ†ΠΈΡŽ, ΡΠΊΡΠΏΡ€Π΅ΡΡΠΈΡŽ MDR1, Π² качСствС Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΠ³ΠΎ прогностич Сского ΠΌΠ°Ρ€ΠΊ Π΅Ρ€Π°, ΠΈΠΌΠ΅Π΅Ρ‚ смысл ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Ρ‚ΡŒ ΠΈΠΌΠ΅Π½Π½ΠΎ Ρƒ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… с мСтастатичСскими опухолями, Π½Π΅ ΡΠ²Π»ΡΡŽΡ‰ΠΈΠΌΠΈΡΡ сСминомой

    Preparing for a Northwest Passage: A Workshop on the Role of New England in Navigating the New Arctic

    Get PDF
    Preparing for a Northwest Passage: A Workshop on the Role of New England in Navigating the New Arctic (March 25 - 27, 2018 -- The University of New Hampshire) paired two of NSF\u27s 10 Big Ideas: Navigating the New Arctic and Growing Convergence Research at NSF. During this event, participants assessed economic, environmental, and social impacts of Arctic change on New England and established convergence research initiatives to prepare for, adapt to, and respond to these effects. Shipping routes through an ice-free Northwest Passage in combination with modifications to ocean circulation and regional climate patterns linked to Arctic ice melt will affect trade, fisheries, tourism, coastal ecology, air and water quality, animal migration, and demographics not only in the Arctic but also in lower latitude coastal regions such as New England. With profound changes on the horizon, this is a critical opportunity for New England to prepare for uncertain yet inevitable economic and environmental impacts of Arctic change
    • …
    corecore